Skip to main content
. Author manuscript; available in PMC: 2018 Jul 1.
Published in final edited form as: Int J Drug Policy. 2017 Jun 16;45:56–63. doi: 10.1016/j.drugpo.2017.05.037

Table 1.

Characteristics of study participants by their willingness to pay for opioid agonist treatment, stratified by experience (N=855)

Willing to pay for OAT

Currently on OAT (N=434) Previously on OAT (N=108) Never on OAT (N=313)

Yes
N=211
No
N=223
P-value Yes
N=55
No
N=53
P-value Yes
N=112
No
N=201
P-value

Sex (Male) 167 (79.2) 173 (77.6) 0.6918 40 (72.7) 39 (73.6) 0.9199 98 (87.5) 151 (75.1) 0.0088

Age – median (IQR) 37 (32–43) 36 (32–43) 0.2023 36 (31–43) 38 (31–46) 0.9094 32 (27–38) 35 (30–40) 0.0177

City 0.0088 0.1579 0.2772
 Kyiv 61 (28.9) 79 (35.4) 19 (34.6) 16 (30.2) 39 (34.8) 68 (33.8)
 Odesa 25 (11.8) 22 (9.9) 6 (10.9) 4 (7.6) 10 (8.9) 26 (12.9)
 Mykolaiv 41 (19.4) 64 (28.7) 11 (20.0) 21 (39.6) 5 (4.6) 19 (9.5)
 Dnipro 57 (27.0) 45 (20.2) 12 (21.8) 10 (18.8) 20 (17.9) 37 (18.4)
 Lviv 27 (12.8) 13 (5.8) 7 (12.7) 2 (3.8) 38 (33.9) 51 (25.4)

Employment 0.0275 0.4169 0.1556
 Full time/Part time 113 (53.5) 91 (40.8) 30 (54.6) 23 (43.4) 54 (48.2) 75 (37.3)
 Temporary/Seasonal/Day laborer 31 (14.7) 39 (17.5) 8 (14.5) 7 (13.2) 18 (16.1) 35 (17.4)
 Not employed 67 (31.8) 93 (41.7) 17 (30.9) 23 (43.4) 40 (35.7) 91 (45.3)

Monthly Income (>1200 UAH) 140 (66.4) 122 (54.7) 0.0132 38 (69.1) 37 (69.8) 1.0000 85 (75.9) 123 (61.2) 0.0083

Injection drug use duration (>5 years) 208 (98.6) 220 (98.7) 1.0000 54 (98.2) 53 (100.0) 1.0000 98 (87.5) 172 (85.6) 0.7329

Injected drugs in the last 30 days 45 (21.3) 55 (24.7) 0.4093 46 (83.6) 46 (86.8) 0.7880 108 (96.4) 196 (97.5) 0.7264

Frequent drug injecting (>20 days in the last 30 days) 8 (3.8) 15 (6.7) 0.2018 19 (34.6) 18 (34.0) 0.9491 76 (67.9) 131 (65.2) 0.6307

Alcohol use disorder 48 (22.8) 67 (30.0) 0.0852 22 (40.0) 15 (28.3) 0.2280 58 (51.8) 106 (52.7) 0.8718

Moderate to severe depression 86 (40.8) 110 (49.3) 0.0730 37 (67.3) 34 (64.2) 0.8398 69 (61.6) 131 (65.2) 0.5288

Positive attitude towards OAT – median (IQR) 9 (8–10) 9 (7–10) 0.0370 9 (7–10) 7 (4–9) 0.0002 8 (6–9) 7 (4–9) 0.4111

Negative attitude towards OAT – median (IQR) 2 (1–4) 3 (2–5) 0.0008 3 (2–5) 3 (2–5) 0.7248 4 (2–5) 3 (2–5) 0.1250

Family/friends support participation in OAT 145 (68.7) 132 (59.2) 0.0390 34 (61.8) 20 (37.7) 0.0205 46 (41.1) 84 (41.8) 0.9014

HIV status (self-reported) 0.9592 0.3495 0.0498
 Positive 96 (45.5) 98 (43.9) 27 (49.1) 19 (35.9) 20 (17.9) 61 (30.4)
 Negative 105 (49.8) 114 (51.2) 24 (43.6) 27 (50.9) 51 (45.5) 75 (37.3)
 Unknown 10 (4.7) 11 (4.9) 4 (7.3) 7 (13.2) 41 (36.6) 65 (32.3)

Registration at Narcology service 41 (36.6) 74 (36.8) 0.9707

Tried to enter OAT but failed 19 (17.0) 18 (9.0) 0.0443

OAT type (Methadone) 165 (78.2) 179 (80.3) 0.5950 35 (63.6) 39 (73.6) 0.3043

Duration on OAT (months) – median (IQR) 33.5 (13.1–61.3) 37.4 (19.8–62.1) 0.2496 4.0 (0.1–7.0) 3.0 (0.1–8.1) 0.9826

Received psychological counseling on OAT site 148 (70.1) 130 (58.3) 0.0102 23 (41.8) 28 (52.8) 0.3352

Received medical services on OAT site 96 (45.3) 75 (33.6) 0.0115 12 (21.8) 11 (20.7) 0.8926

Satisfied with dosage 177 (83.9) 187 (83.9) 0.9933 48 (87.3) 47 (88.7) 0.8223

Experienced short interruptions in treatment 42 (19.9) 46 (20.6) 0.8516 19 (34.6) 10 (18.9) 0.0661

Legend: OAT : opioid agonist treatment.

Currency exchange: US$1 = 8UAH